NCT01249378

Brief Summary

In this study, the investigators are interested in investigating how the emulsification state and amount of fat in a meal can modify the kinetics of postprandial lipemia and inflammatory outcomes (including endotoxemia) in obese vs lean subjects. 10 lean and 10 obese volunteers will come 3 times (\>3 weeks apart) at the investigation center to receive a standard breakfast containing milk fat (10 g non emulsified, or 40 g non emulsified, or 40 g finely emulsified). 13C triglyceride stable isotopes will allow to follow the metabolic fate of fatty acids and calculate lipid oxidation by breath test. Blood sampling throughout digestion will allow to measure metabolic, lipid and inflammation parameters. Stool will be analysed to determine lipid losses in faeces and to phenotype microbiota.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Mar 2010

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2010

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 29, 2010

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

November 29, 2010

Status Verified

November 1, 2010

Enrollment Period

2.9 years

First QC Date

July 13, 2010

Last Update Submit

November 26, 2010

Conditions

Keywords

NutritionLipidDigestionEndotoxemiaInflammationMetabolismStable IsotopeObesity

Outcome Measures

Primary Outcomes (1)

  • Time of appearance of plasma triglyceride peak after ingestion of emulsified vs unemulsified fat during breakfast

    four hours

Secondary Outcomes (1)

  • Kinectics of: Lipid oxidation plasma metabolite concentrations Endotoxemia and plasma markers of inflammation 13 C-fatty acid appearance in plasma

    one day

Study Arms (3)

10 g non emulsified of milk fat

ACTIVE COMPARATOR

They are compared using the repeated measurements taken within subjects

Other: All subjects receive three sequences of a standard breakfast

40 g non emulsified of milk fat

ACTIVE COMPARATOR

The subjects receive three sequences of different breakfasts. They are compared using the repeated measurements taken within subjects.

Other: All subjects receive three sequences of a standard breakfast

40 g finely emulsified of milk fat

ACTIVE COMPARATOR

The subjects receive three sequences of different breakfasts. They are compared using the repeated measurements taken within subjects.

Other: All subjects receive three sequences of a standard breakfast

Interventions

All subjects receive three sequences of a standard breakfast containing : * 10 g non emulsified * or 40 g non emulsified * or 40 g finely emulsified of milk fat with stable isotope (13C triglyceride). The administration order is determined by randomized allocation. The wash-out period is three weeks. There are not diet or exercise interventions. Only, one week before and three days after, the subjects consume neither naturally enriched in 13C foods or pre/probiotics. In addition, three days before and three days after each test, the subjects receive dietary instructions

10 g non emulsified of milk fat40 g finely emulsified of milk fat40 g non emulsified of milk fat

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • No smokers
  • BMI 18 to 35 kg/m2
  • Moderate physical activity
  • Safety subject during medical consultation

You may not qualify if:

  • Medical history which may affect lipid metabolism and gut microflora (renal -cardiovascular -hepatic- endocrine-inflammatory diseases)
  • Drug use that could affect lipid metabolism and gut microflora (steroids, antilipemic agent, anorectic, antibiotic)
  • Inflammatory or infectious disease in the last three month
  • C Reactive Protein \> 20
  • Prebiotic or probiotic high consumers (several times a day)
  • Eating disorder
  • Claustrophobic subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon,Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA)

Lyon, 165 Chemin Du Grand Revoyet, 69495 Pierre Bénite Cedex, France

RECRUITING

Related Publications (4)

  • Vors C, Drai J, Pineau G, Laville M, Vidal H, Laugerette F, Michalski MC. Emulsifying dietary fat modulates postprandial endotoxemia associated with chylomicronemia in obese men: a pilot randomized crossover study. Lipids Health Dis. 2017 May 25;16(1):97. doi: 10.1186/s12944-017-0486-6.

  • Vors C, Pineau G, Drai J, Meugnier E, Pesenti S, Laville M, Laugerette F, Malpuech-Brugere C, Vidal H, Michalski MC. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial. J Clin Endocrinol Metab. 2015 Sep;100(9):3427-35. doi: 10.1210/JC.2015-2518. Epub 2015 Jul 7.

  • Vors C, Drai J, Gabert L, Pineau G, Laville M, Vidal H, Guichard E, Michalski MC, Feron G. Salivary composition in obese vs normal-weight subjects: towards a role in postprandial lipid metabolism? Int J Obes (Lond). 2015 Sep;39(9):1425-8. doi: 10.1038/ijo.2015.71. Epub 2015 Apr 28.

  • Vors C, Pineau G, Gabert L, Drai J, Louche-Pelissier C, Defoort C, Lairon D, Desage M, Danthine S, Lambert-Porcheron S, Vidal H, Laville M, Michalski MC. Modulating absorption and postprandial handling of dietary fatty acids by structuring fat in the meal: a randomized crossover clinical trial. Am J Clin Nutr. 2013 Jan;97(1):23-36. doi: 10.3945/ajcn.112.043976. Epub 2012 Dec 12.

Related Links

MeSH Terms

Conditions

ObesityEndotoxemiaInflammation

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBacteremiaSepsisInfectionsToxemiaSystemic Inflammatory Response SyndromePathologic Processes

Central Study Contacts

Martine LAVILLE, PU-PU

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 13, 2010

First Posted

November 29, 2010

Study Start

March 1, 2010

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

November 29, 2010

Record last verified: 2010-11

Locations